CogCan: Risk and Resilience Factors Associated wit...

Campus Map

Working with Coventry University

Working at Coventry University

Coventry University is a diverse and exciting place to work and we share the enthusiasm of our staff and students to be the best at whatever they choose to do. As one of the City’s biggest employers, we offer some impressive benefits for our staff and are committed to delivering the very best opportunities. We have a comprehensive training, personal and professional development programme that provides our employees with the skills to enhance their performance in the workplace and grow in their careers. There are pension schemes, a generous holiday allowance and flexible working opportunities as well as lifestyle benefits including childcare vouchers, discounted membership to the £4 million sports and recreation centre and schemes such as Cycle to Work and the CU Car Share initiative.

View current job vacancies.


Staff portal

Access the central point of information for all staff across the University.


Student Portal

Check your assessments, access Solar and get course information.


CogCan: Risk and Resilience Factors Associated with Cognitive Changes Following Androgen Deprivation Therapy in Prostate Cancer Patients


Prostate Cancer UK




Coventry University, University of Birmingham; King’s College London; University Hospitals Birmingham

Project Team

General Information

Prostate cancer survivors receiving longterm androgen deprivation therapy (ADT) sometimes experience unpleasant and debilitating side-effects, including decline in some thinking abilities. Prostate cancer patients are being observed to help us understand the factors that contribute to the risk of developing these effects on thinking – or the ability to resist them.

Project Objectives

The aim of this project is to identify which thinking skills are affected by androgen deprivation therapy (ADT) and whether some people are more at risk of decline in thinking skills performance. This will be done by following patients who do and who do not receive ADT for an 18 month period. This is an innovative project combining: (1) cognitive testing (tests of thinking skills such as memory), (2) psychosocial measures (e.g. mood, fatigue), (3) brain imaging and (4) blood biomarkers (to assess testosterone levels and genetic risk of cognitive decline).

The study will allow us to record potential risk factors prior to starting ADT to identify baseline factors that predict performance on tasks at follow-up. The study offers a unique opportunity to develop a risk profile for cognitive decline (changes in thinking skill) in men receiving ADT that could be used by treating doctors.

Research Impact

Currently, we do not have a clear understanding of the factors that might make patients receiving ADT more at risk to changes in thinking skills (for example, age-related brain changes), or whether there are protective factors that might make a person more resilient to these changes (for example, good psychosocial status). By providing this information, our study would offer men and their prescribing doctors evidence-based information to support decision-making. It would also allow us to develop specific, focused interventions to mitigate the impact of changes in thinking skills on everyday functioning (for example, through strategies to improve memory or aid planning skills).